Heart is a major organ that is classified as the hardest working muscle
in the body. The heart pumps blood non-stop throughout the body thru the
circulatory system. It is responsible in supplying oxygen and nutrients to body
tissues while getting rid of wastes such as carbon dioxide. Heart- indeed is the
powerhouse of the human body and it is only right that we should take good care
of it.
One serious cardiovascular condition is heart attack and it can trigger cardiac
arrest which is one of the leading causes of deaths in the world.
Heart attacks
can have devastating effects that will suddenly change the way of living of any
individual afflicted by this. But, as innovations are taking place with latest
medical breakthroughs, prevention and proper guidelines on cardiovascular
diseases are within reach through the right connections.
The partnership between Zuellig Pharma Corporation and Amgen Philippines
Inc., aims to heighten the awareness on cardiovascular diseases or CVD through various
initiatives and educational campaigns. This partnership targets to improve the
way CVD is prevented and being properly managed.
In a recent report by pas.gov, there are more than 130,000 deaths
associated with cardiovascular diseases in the Philippines alone in 2016. CVD
is a complex health condition that has many risk factors as it develops. One of
the most common risk is Dyslipidemia which is caused by having abnormal level
of lipids in a person’s blood.
Lipids also known as fats are responsible in maintaining power to the
cells wherein cholesterol is needed in the production of bodily hormones and
bile acids essential for good digestion.
The human body has both good and bad cholesterol. Low Density
Lipoprotein or LDL-C is recognized as bad cholesterol and having high levels of
this can contribute to the development of cardiovascular diseases. Increased
LDL-C in the bloodstream predisposes an individual to developing atherosclerotic
plaque deposits which blocks the arteries of the heart leading to stroke or
heart attack. Maintaining the levels of LDL-C in good balance will significantly
lower the chances of having cardiovascular diseases.
For years, doctors usually prescribe statins as treatment in lowering
LDL-C in most patients. With the onset of various health conditions not all patients
treated with statins have successful results which they would need an
innovative approach. Having access to latest treatments will help manage dyslipidemia
effectively which result to just the right levels of lipids while improving the way of living of patients.
Good thing that Amgen Philippines Inc. and Zuellig Pharma Corporation
have the heart in committing to the improvement of the lives of dyslipidemia patients
and their families by providing sound information and solution in making
necessary actions in preventing and managing health risks associated with CVD.
Comments
Post a Comment